We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, USP to Update Monographs for At-Risk Products
FDA, USP to Update Monographs for At-Risk Products
May 3, 2010
Drugmakers may get updated U.S. Pharmacopeia (USP) monographs for products at risk of being counterfeited or adulterated as part of the FDA’s efforts
to tighten control of the pharmaceutical supply chain.